Monday, Nov 30th

Last update06:44:16 AM GMT

You are here News Health FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel

FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel

E-mail Print PDF

In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.


Most Recent Related Stories...

Despite promise, Turing pharmaceuticals opts to keep list price of Daraprim high

Deraprim- Despite a promise from its chief executive two months ago, Turing Pharmaceuticals said Wednesday it...

Federal Court: Restrictive WI Abortion Law Is Unconstitutional, Endangers Women's Health

Wisc. abortion law unconstitutionalA Wisconsin law that requires abortion providers to get admitting privileges at nearby hospitals is unconstitutional,...

Frank Gifford suffered from brain disease CTE, family says

Frank Gifford had CTEPro Football Hall of Famer Frank Gifford, who died this past summer of natural causes, suffered...

CDC says E. coli outbreak linked to Chipotle restaurants now involves six states

Chipolte E.coli outbreak is in six statesAn outbreak of E. coli that was first reported in the Pacific Northwest and linked to...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!